EGFR-HER2 inhibitor Vandetanib trifluoroacetate, Purity ≥98%

Cat. No.: X24-05-ZQ653

EGFR-HER2 inhibitor Vandetanib trifluoroacetate, Purity ≥98%

Synonym: 338992-53-3; Zactima trifluoroacetate; ZD6474 trifluoroacetate; ZD-6474 trifluoroacetate; ZD 6474 trifluoroacetate; EGFR-HER2 inhibitor

  • CAS Number: 338992-53-3
  • Compound CID: 17973223
Product Size
50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Vandetanib trifluoroacetate is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR/HER1, VEGFR2, and VEGFR3.
Molecular Weight
589.38
Molecular Formula
C24H25BrF4N4O4
Targets
EGFR/HER1: 500 nM; VEGFR2: 40 nM; VEGFR3: 110 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Vandetanib trifluoroacetate is used to research its dual inhibition of VEGFR and EGFR in cancer treatment.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.